Latest news for Shikun & Binui (OTC:SKBNF) Stock

Shikun & Binui Ltd is an Israel-based company that carries out public-private partnership projects that focus on the financing, construction, and operation of infrastructure and civil engineering projects; development and construction of residential buildings and commercial projects; operation of rental properties; development of power generation facilities based on solar photovoltaic energy; solar thermal energy; and operation of water desalination and purification initiatives. The construction segments make up the majority of the company's revenue. Shikun & Binui's key areas of operation are the Americas, Africa, Europe, and Israel.

Shikun & Binui Ltd

News

Events

AAPL

Apple Watch Starts At $399 For Its GPS Version; $499 For Its GPS + Cellular Version

WIIM

HOOD

Robinhood shares are trading higher, possibly ahead of tomorrow's presentation at the Goldman Sachs Communacopia + Technology Conference.

Cantor Fitzgerald analyst Prakhar Agrawal reiterates ORIC Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORIC#NASDAQ">ORIC</a>) with a Overweight.

Reiteration

Analyst Ratings

ORIC

Cantor Fitzgerald Reiterates Overweight on ORIC Pharmaceuticals

UTime Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTO#NASDAQ">WTO</a>) shares are trading lower by 26.1% to $0.04 Monday afternoon after the company announced a <a href="https://www.benzinga.com/pressreleases/24/09/g40775812/utime-limited-announces-1-for-25-reverse-share-split">1-for-25 reverse share split</a>.
The reverse split will be effective on or around the open of September 11. This move aims to meet Nasdaq&#8217;s minimum $1.00 bid price requirement for continued listing. 
The reverse split will reduce the total number of outstanding shares from 450 million to approximately 18 million. No fractional shares will be issued, and proportionate adjustments will be made to outstanding securities.
Read Also: <a href="https://www.benzinga.com/news/24/09/40777440/why-sintx-technologies-stock-is-up-100-today">Why SINTX Technologies Stock Is Up 100% Today</a>
<h2 class="wp-block-heading">Should I Sell My WTO Stock?</h2>
Whether to sell or hold a stock largely depends on an investor's strategy and risk tolerance. Swing traders may sell an outperforming stock to lock in a capital gain, while long-term investors might ride out the turbulence in anticipation of further share price growth.
Similarly, traders willing to minimize losses may sell a stock that falls a certain percentage, while long-term investors may see this as an opportunity to buy more shares at a discounted price.
Shares of UTime have lost 86.46% year to date. This compares to the average annual return of -78.0%, meaning the stock has underperformed its historical averages. Investors can compare a stock's movement to its historical performance to gauge whether this is a normal movement or a potential trading opportunity. 
For analysis tools, charting data and access to exclusive stock news, check out <a href="https://pro.benzinga.com/">Benzinga PRO. Try it for free.</a>
WTO has a 52-week high of $2.49 and a 52-week low of $0.05.

Why UTime (WTO) Stock Is Down 26% Today

With student loan debt, a tough job market and rising living costs, Gen Z faces unique financial challenges.
Don't Miss:
<ul>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/red-ventures"> The percentage may shock you</a>.</li>
</ul>
While many factors are beyond their control, financial guru Suze Orman argues that Gen Z's focus on fashion exacerbates their financial struggles.
"They don't understand the value of compounding interest and that the key to their financial independence is their age," Orman told The Wall Street Journal. "[Young people] don't get that. They would rather dress cool, go on their TikToks."
Trending: Elon Musk&#8217;s secret mansion in Austin revealed through court filings. <a href="https://www.benzinga.com/money/elon-musk-secret-mansion-austin-nada">Here&#8217;s how to invest in the city&#8217;s growth before prices go back up.</a>
However, not all experts agree with <a href="https://www.benzinga.com/personal-finance/24/06/39278008/youre-setting-up-the-entire-family-for-trouble-suze-orman-warns-against-this-common-retirement-m">Orman's assessment</a>. Some argue that while they may not increase their wealth the way Orman would like them to, they are investing.
"Surveys and studies have shown that <a href="https://www.benzinga.com/personal-finance/24/06/39296729/i-am-no-longer-your-bank-account-suze-orman-tells-gen-xers-and-boomers-to-cut-off-freeloading-ad">Gen Z</a> is already investing earlier than generations before them," said Alex Blackwood, CEO and co-founder at Mogul Club. "Even for those without the funds to invest significantly, two-thirds believe in the opportunity of the stock market to build wealth."
While there may be disagreement over whether Orman is correct in her assessment of Gen Z's spending habits, there's no denying that TikTok holds significant value for this generation. In addition to being a platform for spending, TikTok has become a lucrative avenue for Gen Zers to earn money as influencers.
See Also: The average American couple has saved this much money for retirement — <a href="http://www.benzinga.com/money/smartasset">How do you compare</a>?
"Depending on the agreements arranged with brands and influencers, the pay can range from $100 a post to a few thousand dollars depending on various factors such as platform and number of followers," said Mawuli Vodi, speaker, educator and author at Financially Present. "This money can more than satisfy the monthly investment contribution Orman is referring to, even if it happens to be on TikTok."
Vodi also notes that dressing cool on TikTok can help Gen Zers make money if they are influencers or brand ambassadors. She points out that social media has changed to a point that gamers can stream live and earn money by playing video games.
"The current influencer and content creator climate allows young people to monetize their efforts more than they would have if they went door to door mowing lawns and shoveling snow," Vodi said. "Considering the power of TikTok, YouTube, Snapchat, Discord, Reddit and Twitch, there are multiple platforms for younger generations to use and monetize – which can further their financial contributions to investing."
Trending: A billion-dollar investment strategy with minimums as low as $10 — <a href="https://www.benzinga.com/money/fundrise-flagship-fund">you can become part of the next big real estate boom today.</a>
Michael Santiago, senior financial editor at Annuity.org, said that Orman's stance on Gen Z needing to invest at an early age is on target.
"However, I cannot agree with her generalization of young people as financially mindless and valuing ‘dressing cool' and cultivating their social media profile above all else," he said. "There are more than a few Gen Zers that exhibit troubling behavior, but we need to assess this demographic in a thoughtful manner."
Read Next:
<ul>
<li>Founder of Personal Capital and ex-CEO of PayPal <a href="https://www.benzinga.com/money/evergreen-money">re-engineers traditional banking with this new high-yield account — start saving better today.</a></li>
</ul>

Personal Finance

Suze Orman Says Gen Z's Fashion Obsession Hinders Wealth Building – 'They Would Rather Dress Cool, Go On Their TikToks'

Cantor Fitzgerald analyst Prakhar Agrawal reiterates MoonLake (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLTX#NASDAQ">MLTX</a>) with a Overweight.

MLTX

Cantor Fitzgerald Reiterates Overweight on MoonLake

Biotech

General

INSP

TEVA

VVOS

Apple Announces New Sleep Apnea Features On Apple Watch; Stocks With The Same Technology See Volume

Cantor Fitzgerald analyst Li Watsek reiterates Kura Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KURA#NASDAQ">KURA</a>) with a Overweight.

KURA

Cantor Fitzgerald Reiterates Overweight on Kura Oncology

Cantor Fitzgerald analyst Charles Duncan reiterates KalVista Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KALV#NASDAQ">KALV</a>) with a Overweight.

KALV

Cantor Fitzgerald Reiterates Overweight on KalVista Pharma

Investors with a lot of money to spend have taken a bullish stance on Verizon Communications (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with VZ, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 8 uncommon options trades for Verizon Communications.
This isn't normal.
The overall sentiment of these big-money traders is split between 62% bullish and 37%, bearish.
Out of all of the special options we uncovered, 5 are puts, for a total amount of $173,520, and 3 are calls, for a total amount of $117,104.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $38.0 and $46.0 for Verizon Communications, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Verizon Communications stands at 4005.29, with a total volume reaching 5,562.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Verizon Communications, situated within the strike price corridor from $38.0 to $46.0, throughout the last 30 days.
<h3>Verizon Communications Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1725902143_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>VZ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$4.85</td>
<td>$4.8</td>
<td>$4.85</td>
<td>$38.00</td>
<td>$59.1K</td>
<td>30</td>
<td>1</td>
</tr>
<tr>
<td>VZ</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/13/24</td>
<td>$0.4</td>
<td>$0.37</td>
<td>$0.4</td>
<td>$42.00</td>
<td>$40.1K</td>
<td>382</td>
<td>1.1K</td>
</tr>
<tr>
<td>VZ</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$4.1</td>
<td>$3.9</td>
<td>$3.9</td>
<td>$40.00</td>
<td>$39.0K</td>
<td>12.9K</td>
<td>0</td>
</tr>
<tr>
<td>VZ</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$3.3</td>
<td>$3.25</td>
<td>$3.26</td>
<td>$42.00</td>
<td>$32.6K</td>
<td>2.3K</td>
<td>228</td>
</tr>
<tr>
<td>VZ</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$1.48</td>
<td>$1.46</td>
<td>$1.46</td>
<td>$41.00</td>
<td>$31.3K</td>
<td>9.5K</td>
<td>542</td>
</tr>
</tbody>
</table>

<h3>About Verizon Communications</h3>
Wireless services account for about 70% of Verizon Communications' total service revenue and nearly all of its operating income. The firm serves about 93 million postpaid and 21 million prepaid phone customers (following the acquisition of Tracfone) via its nationwide network, making it the largest US wireless carrier. Fixed-line telecom operations include local networks in the Northeast, which reach about 29 million homes and businesses and serve about 8 million broadband customers. Verizon also provides telecom services nationwide to enterprise customers, often using a mixture of its own and other carriers' networks.
<h3>Present Market Standing of Verizon Communications</h3>
<ul>
<li>Currently trading with a volume of 8,682,319, the VZ's price is up by 3.0%, now at $42.38. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 43 days.</li>
</ul>
<h3>What Analysts Are Saying About Verizon Communications</h3>
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $43.0.
<ul>
<li>Consistent in their evaluation, an analyst from Keybanc keeps a Overweight rating on Verizon Communications with a target price of $44. </li>
<li>Reflecting concerns, an analyst from RBC Capital lowers its rating to Sector Perform with a new price target of $42.</li>
</ul>
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Verizon Communications, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

Behind the Scenes of Verizon Communications's Latest Options Trends

Deep-pocketed investors have adopted a bearish approach towards Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in PG usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 12 extraordinary options activities for Procter &amp; Gamble. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 33% leaning bullish and 58% bearish. Among these notable options, 3 are puts, totaling $580,953, and 9 are calls, amounting to $325,538.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $165.0 and $185.0 for Procter &amp; Gamble, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Procter &amp; Gamble's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Procter &amp; Gamble's whale activity within a strike price range from $165.0 to $185.0 in the last 30 days. 
<h3>Procter &amp; Gamble Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1725902138_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$3.3</td>
<td>$3.2</td>
<td>$3.23</td>
<td>$170.00</td>
<td>$484.5K</td>
<td>2.2K</td>
<td>1.5K</td>
</tr>
<tr>
<td>PG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/04/24</td>
<td>$1.9</td>
<td>$1.88</td>
<td>$1.89</td>
<td>$175.00</td>
<td>$52.9K</td>
<td>98</td>
<td>32</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/27/24</td>
<td>$0.91</td>
<td>$0.9</td>
<td>$0.9</td>
<td>$180.00</td>
<td>$50.4K</td>
<td>237</td>
<td>2.1K</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$5.5</td>
<td>$5.25</td>
<td>$5.3</td>
<td>$185.00</td>
<td>$47.7K</td>
<td>401</td>
<td>90</td>
</tr>
<tr>
<td>PG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$3.85</td>
<td>$3.8</td>
<td>$3.85</td>
<td>$165.00</td>
<td>$43.5K</td>
<td>1.3K</td>
<td>117</td>
</tr>
</tbody>
</table>

<h3>About Procter &amp; Gamble</h3>
Since its founding in 1837, Procter &amp; Gamble has become one of the world's largest consumer product manufacturers, generating more than $80 billion in annual sales. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent more than half of the firm's consolidated total.
<h3>Current Position of Procter &amp; Gamble</h3>
<ul>
<li>Trading volume stands at 2,945,814, with PG's price up by 0.26%, positioned at $176.05.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 37 days.</li>
</ul>
<h3>What Analysts Are Saying About Procter &amp; Gamble</h3>
In the last month, 1 experts released ratings on this stock with an average target price of $190.0.
<ul>
<li>An analyst from DZ Bank has elevated its stance to Buy, setting a new price target at $190. </li>
</ul>
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Procter &amp; Gamble, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Unpacking the Latest Options Trading Trends in Procter & Gamble

Financial giants have made a conspicuous bearish move on SolarEdge Technologies. Our analysis of options history for SolarEdge Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>) revealed 11 unusual trades.
Delving into the details, we found 36% of traders were bullish, while 63% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $237,480, and 7 were calls, valued at $345,840.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $19.0 and $30.0 for SolarEdge Technologies, spanning the last three months.
<h3>Insights into Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in SolarEdge Technologies's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to SolarEdge Technologies's substantial trades, within a strike price spectrum from $19.0 to $30.0 over the preceding 30 days.
<h3>SolarEdge Technologies Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1725902133_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SEDG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/27/24</td>
<td>$1.7</td>
<td>$1.47</td>
<td>$1.47</td>
<td>$19.00</td>
<td>$113.8K</td>
<td>20</td>
<td style="text-align: right;">774</td>
</tr>
<tr>
<td>SEDG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$3.3</td>
<td>$3.25</td>
<td>$3.25</td>
<td>$25.00</td>
<td>$97.1K</td>
<td>1.8K</td>
<td style="text-align: right;">504</td>
</tr>
<tr>
<td>SEDG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$7.1</td>
<td>$7.0</td>
<td>$7.1</td>
<td>$20.00</td>
<td>$66.7K</td>
<td>165</td>
<td style="text-align: right;">110</td>
</tr>
<tr>
<td>SEDG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$4.2</td>
<td>$4.1</td>
<td>$4.17</td>
<td>$22.50</td>
<td>$62.9K</td>
<td>460</td>
<td style="text-align: right;">152</td>
</tr>
<tr>
<td>SEDG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$3.25</td>
<td>$3.2</td>
<td>$3.25</td>
<td>$25.00</td>
<td>$55.5K</td>
<td>1.8K</td>
<td style="text-align: right;">176</td>
</tr>
</tbody>
</table>

<h3>About SolarEdge Technologies</h3>
SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers.
Having examined the options trading patterns of SolarEdge Technologies, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Present Market Standing of SolarEdge Technologies</h3>
<ul>
<li>Trading volume stands at 1,672,492, with SEDG's price up by 2.0%, positioned at $19.88.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 51 days.</li>
</ul>
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for SolarEdge Technologies, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

SEDG

SolarEdge Technologies Unusual Options Activity For September 09

Friday's jobs report marked the second month in a row with substantially fewer jobs created than analysts expected—renewing fears that a recession is imminent, if not already underway.
With all three major market indices sliding on the news, the selloff may just be getting started.
And none other than Warren Buffett—the legendary "Oracle of Omaha" is leading the charge…
Warren Buffett's Berkshire Hathaway has dumped millions of shares of various stocks over the last few months—and is now sitting on a record cash position of $276 billion. The massive selling is reminiscent of Berkshire's stock sales ahead of 2022—the worst year for markets since the 2008 financial crisis.
Here are the top 3 stocks Warren Buffett is selling now.
Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>)
Berkshire Hathaway has cut its position in Apple by nearly 50% in recent months, reducing its position from over $135 billion to just over $84 billion today.
When asked about the move at the most recent conference for Berkshire Hathaway shareholders in May, Buffett said the move was for tax reasons.
But there's no denying that Apple's earnings and revenue growth have slowed in recent months.
Last quarter, the tech giant reported year-over-year quarterly revenue growth of just 4.9%. Earnings growth came in at 7.9%
Bank of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>)
Last quarter, Berkshire Hathaway reduced its position on Bank of America by $37 billion.
The move comes as Bank of America reports negative quarterly earnings growth of 6.8%. Revenues also shrank last quarter, retreating by 0.8%.
Analysts are forecasting a 10% dip in growth for BAC over the next quarter. Banks are typically hard-hit by recession, as rising defaults cut into their earnings. In any case, it seems that mainstream analysts see the same potential for trouble for BAC in the months ahead that Warren Buffett does.
Chevron Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>)
Buffett has been very bullish on oil and gas stocks in the post-Covid years, so it's interesting that he's unloaded 30.6 million shares of the energy giant last quarter.
At one time, Chevron was the fifth-largest holding in Berkshire Hathaway's portfolio. But it's possible that Buffett sees a prolonged period of lower energy prices ahead, since recessions and other economic drawdowns always reduce energy demand, and therefore profits for oil and gas companies.
Nationally, gas prices are already over 50 cents cheaper per gallon than they were a year ago… and they're still falling, thanks to a few factors including an unusually mild hurricane season and the rise of electric vehicles.
Chevron, not coincidentally, is joining a host of energy companies coming under pressure. It reported a decline in quarterly earnings of 26.2%, and grew revenues by just 4.8% last quarter on a year-over-year basis.
If you want to find your own stocks to Buy you can use my Strategy of <a href="http://Buy at this blue line and you'll have a shot at trading profitably">Buying at this blue line and you too can have a shot at trading profitably</a>
Image via Shutterstock

Opinion

Trading Ideas

Three Stocks Warren Buffett Is Selling as a Recession Nears

Apple Announces New S10 Chip In Apple Watch Series 10

Oracle Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) shares are on watch Monday ahead of the company&#8217;s first-quarter earnings set to be released <a href="https://www.benzinga.com/trading-ideas/technicals/24/09/40772573/ai-deals-drive-oracle-momentum-will-q1-earnings-keep-stock-in-fast-lane">after the closing bell.</a>
The Details:
Investors will be watching Oracle's cloud service revenue amid growing AI demand and previously announced deals with OpenAI and Google. Analysts expect the company to report quarterly earnings of $1.32 per share on revenue of $13.23 billion, according to estimates from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>.&nbsp;
Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40754522/whats-going-on-with-coinbase-stock-today">What&#8217;s Going On With Coinbase Stock Today?</a>
According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Oracle stock has gained over 20% in the last 12 months and is trading above its 50-day moving average of $138.64. Investors can gain exposure to the stock via Pacer Funds Pacer Data And Digital Revolution ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRFK#NYSE">TRFK</a>) and IShares Expanded Tech-Software Sector ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/IGV#BATS">IGV</a>).
<h3 class="wp-block-heading">ORCL Stock Prediction 2024: </h3>
When buying a stock for a longer time horizon, it is important for investors to assess where they think the stock is headed in the future.
When mapping a stock's future trajectory, investors should consider factors including the future earnings expectations and expected performance against a benchmark.
Oracle's revenue has grown at an average rate of 7.12% annually over the past 5 years. The average 1-year price target from analysts is $149.74, representing an expected 5.81% upside in 2025.
While past performance is not a guarantee of future results, investors should also look at a stock's historical performance when compared to both a benchmark index and the company's peers. Shares of Oracle have seen an annualized return of 18.35%, outperforming the S&amp;P500 index by 11.98%. This compares to 17.63% growth in the overall Information Technology sector. Oracle has a beta of 1.15.
ORCL Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Oracle shares are down 0.47% at $142.47 at the time of publication Monday.
Read Also:
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40753645/roaring-kitty-posts-again-whats-going-on-with-gamestop-amc-chewy-stocks">Roaring Kitty Posts Again: What&#8217;s Going On With GameStop, AMC, Chewy Stocks?</a></li>
</ul>
Image: Shutterstock

Movers

ORCL

TRFK

What's Going On With Oracle Stock?

Nucor shares are trading higher JP Morgan upgraded the stock from Neutral to Overweight and raised its price target from $170 to $174.

New Apple Watch To Be 9.7mm, 10% Thinner Then Previous Designs; Has Ability To Play Out Loud Through Speakers; 50 Meter Water Resistant; Fasting Charging Apple Watch Ever, ~30 Mins = 80% Battery Charge

Cantor Fitzgerald analyst Josh Schimmer reiterates Jasper Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JSPR#NASDAQ">JSPR</a>) with a Overweight.

Jasper Therapeutics, Inc. - Class A Common Stock

JSPR

Cantor Fitzgerald Reiterates Overweight on Jasper Therapeutics

FMC Corporation&#39;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fmc#NYSE">FMC</a>) shares have gained 9.6% over the past three months. The company has also outperformed its industry&#39;s decline of 7.8% over the same time frame. FMC has also topped the S&amp;P 500&#39;s roughly 2.9% rise over the same period.
Let&#39;s dive into the factors behind this Zacks Rank #3 (Hold) stock&#39;s price appreciation.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/25/76914.jpg?v=1710638083" style="height:412px; width:610px" />
Image Source: Zacks Investment Research
<h2>New Products, Restructuring Actions Aid FMC Stock</h2>
FMC delivered better-than-expected results in the second quarter on the back of higher volumes. It saw improved demand in the quarter, leading to an increase in sales volumes, especially in the United States and Brazil. The company is gaining from efforts to expand its product portfolio through new product launches and restructuring actions.
FMC is investing in technologies as well as new product launches to enhance value to the farmers. New products launched in Europe, North America and Asia are gaining significant traction. Product introductions are expected to support the company&#39;s results this year.
The company generated $590 million in sales in 2023 from new products launched in the past five years. It expects revenues from new products to grow by roughly $200 million in 2024. It expects a significant amount of volume growth to come from new products in the second half of 2024. FMC is seeing strong gains in new products including Coragen eVo and Premio Star insecticides and the Onsuva fungicide in Latin America.
The acquisition of BioPhero ApS, a Denmark-based pheromone research and production company, also adds biologically produced state-of-the-art pheromone insect control technology to the company&#39;s product portfolio and R&amp;D pipeline, highlighting FMC&#39;s role as a leader in delivering innovative and sustainable crop protection solutions.
FMC is also expected to benefit from reduced input costs, a favorable product mix and its cost-control actions. It benefited from favorable input costs in the second quarter of 2024. FMC is also making progress with its global restructuring and cost-reduction program. It sees benefits from restructuring to contribute $75-$100 million to full-year 2024 adjusted EBITDA, net of inflation.
<div class="chart_embed">
<h3>FMC Corporation Price and Consensus</h3>
<img alt="FMC Corporation Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/18/1725873589.png" style="height:265px; width:576px" title="" />
FMC Corporation price-consensus-chart | FMC Corporation Quote
</div>
<h2>Stocks to Consider</h2>
Better-ranked stocks in the Basic Materials space are Newmont Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nem#NYSE">NEM</a>), Element Solutions Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/esi#NYSE">ESI</a>) and Eldorado Gold Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ego#NYSE">EGO</a>), each sporting a Zacks Rank #1 (Strong Buy).
The Zacks Consensus Estimate for Newmont&#39;s current-year earnings is pegged at $2.82, indicating a rise of 75.2% from year-ago levels. The Zacks Consensus Estimate for NEM&#39;s earnings has increased 16% in the past 60 days. The stock has rallied around 29% in the past year.
The consensus estimate for Element Solutions&#39; current-year earnings has increased by 0.7% in the past 60 days. ESI beat the consensus estimate in three of the last four quarters while delivering in-line results on the other occasion. In this timeframe, it delivered an earnings surprise of around 3.8%, on average.
The Zacks Consensus Estimate for Eldorado Gold&#39;s current year earnings is pegged at $1.35 per share, indicating a year-over-year rise of 136.8%. EGO beat the consensus estimate in each of the last four quarters, with the average earnings surprise being 430.3%. The company&#39;s shares have rallied roughly 61% in the past year.
<a href="https://www.zacks.com/stock/news/2333348/fmc-shares-rise-10-in-3-months-what-s-driving-the-stock?cid=CS-BENZ-FT-analyst_blog|price_surge_/_plunge-2333348">To read this article on Zacks.com click here.</a>

Earnings

Large Cap

Mid Cap

FMC Shares Rise 10% in 3 Months: What's Driving the Stock?

Monday, Cytokinetics, Incorporated&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYTK#NASDAQ">CYTK</a>) announced that data from the Phase 1 study of CK-4021586 (CK-586) were presented in a poster session at the American College of Clinical Pharmacology Annual <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/g40770281/cytokinetics-announces-data-from-phase-1-study-of-ck-4021586" rel="noreferrer noopener">Meeting in Bethesda, MD</a>.
The study met its primary and secondary objectives to evaluate the safety, tolerability, and pharmacokinetics (PK) of single and multiple oral doses of CK-586.
CK-586 is a cardiac myosin inhibitor in development for the potential treatment of a subgroup of patients with symptomatic HFpEF with hypercontractility and ventricular hypertrophy.
The study data showed that CK-586 was safe and well tolerated in healthy participants.
No serious adverse events were observed, and the stopping criteria for the study were not met.
The half-life of CK-586 was observed to be in the range of 14 to 17 hours.
CK-586 demonstrated dose-linearity without a change in half-life over a wide range of exposures, with steady-state appearing evident within seven days of dosing.
Left ventricular ejection fraction (LVEF) and left ventricular fractional shortening (LVFS) decreased from baseline in an exposure-dependent manner, and the pharmacokinetic/pharmacodynamic (PK/PD) relationship appeared shallow and predictable.
The ejection fraction measures how well the heart is functioning. It's expressed as a percentage and indicates how much blood the heart pumps out with each contraction. At the highest single dose of 600 mg, the mean decrease in LVEF was &lt;5%.
These results demonstrate pharmacologic properties that may enable once-daily fixed-dose administration in the future. Preparations for a Phase 2 clinical trial in patients with heart failure with preserved ejection fraction (HFpEF) are underway, and the trial is expected to begin in the fourth quarter of 2024.
Price Action: CYTK stock is up 2.71% at $55.56 at last check Monday.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/09/40776938/stellantis-recalls-1-46m-vehicles-globally-over-safety-software-flaw-details" target="_blank" rel="noreferrer noopener">Stellantis Recalls 1.46M Vehicles Globally Over Safety Software Flaw: Details</a>.</li>
</ul>

Gain an Edge Using Pro's Market Moving News Breaks — 50% OFF

Gain an Edge Using Pro's Market Moving News Breaks — 50% OFF

Comments

Shikun & Binui

News

Latest news for Shikun & Binui (OTC:SKBNF) Stock